Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate

Abstract

Compared with the general population, methotrexate-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and lung cancer. There may be a role for regular skin cancer screening for all RA patients, particularly those receiving immunosuppressive therapy.